Follow
Yaseswini Neelamraju
Yaseswini Neelamraju
PhD candidate
Verified email at virginia.edu
Title
Cited by
Cited by
Year
The human RBPome: from genes and proteins to human disease
Y Neelamraju, S Hashemikhabir, SC Janga
Journal of proteomics 127, 61-70, 2015
1122015
Mutational landscape of RNA-binding proteins in human cancers
Y Neelamraju, A Gonzalez-Perez, P Bhat-Nakshatri, H Nakshatri, ...
RNA biology 15 (1), 115-129, 2018
722018
Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers
Y Gökmen-Polar, IT Vladislav, Y Neelamraju, SC Janga, S Badve
Scientific reports 5 (1), 8765, 2015
622015
Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer
Y Gökmen-Polar, Y Neelamraju, CP Goswami, X Gu, G Nallamothu, ...
Modern pathology 28 (5), 677-685, 2015
522015
Splicing factor ESRP1 controls ER‐positive breast cancer by altering metabolic pathways
Y Gökmen‐Polar, Y Neelamraju, CP Goswami, Y Gu, X Gu, G Nallamothu, ...
EMBO reports 20 (2), e46078, 2019
512019
Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias
TL Olson, HJ Cheon, JC Xing, KC Olson, U Paila, CE Hamele, ...
Blood, The Journal of the American Society of Hematology 138 (8), 662-673, 2021
182021
Database of RNA binding protein expression and disease dynamics (READ DB)
S Hashemikhabir, Y Neelamraju, SC Janga
Database 2015, 2015
132015
Dissecting the expression relationships between RNA-binding proteins and their cognate targets in eukaryotic post-transcriptional regulatory networks
S Nishtala, Y Neelamraju, SC Janga
Scientific Reports 6 (1), 25711, 2016
112016
Uncovering RNA binding proteins associated with age and gender during liver maturation
P Chaturvedi, Y Neelamraju, W Arif, A Kalsotra, SC Janga
Scientific reports 5 (1), 1-10, 2015
82015
Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia
F Rapaport, Y Neelamraju, T Baslan, D Hassane, A Gruszczynska, ...
Leukemia 35 (9), 2688-2692, 2021
52021
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia
L Barreyro, AM Sampson, C Ishikawa, KM Hueneman, K Choi, MA Pujato, ...
Science translational medicine 14 (635), eabb7695, 2022
42022
Targeted detection and quantitation of histone modifications from 1,000 cells
NA Abshiru, JW Sikora, JM Camarillo, JA Morris, PD Compton, T Lee, ...
PloS one 15 (10), e0240829, 2020
22020
Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999
F Rapaport, K Seier, Y Neelamraju, D Hassane, T Baslan, DT Gildea, ...
Blood cancer journal 12 (9), 137, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–13